GMED Globus Medical, Inc. Class A Common Stock
$88,45
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$54–$101
73% of range
تقييم المحللين
BUY
23 analysts
السعر المستهدف
$103
+17% upside
P/E (TTM)
22.3
ROE
12.1%
هامش صافي الربح
18.3%
حول Globus Medical, Inc. Class A Common Stock نظرة عامة على الشركة من ويكيبيديا
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
اقرأ المزيد
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
GMED لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$88.45
القيمة السوقية
—
P/E (TTM)
22.3
ربح السهم (آخر 12 شهرًا)
$3.92
الإيرادات (آخر 12 شهرًا)
$2.94B
عائد التوزيعات
—
ROE
12.1%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$54 – $101
GMED مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$2.94B
2016-12-31
→
2025-12-31
ربح السهم
$3.92
2016-12-31
→
2025-12-31
التدفق النقدي الحر
$589M
2016-12-31
→
2025-12-31
الهوامش
18.3%
2016-12-31
→
2023-12-31
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
GMED
متوسط الأقران
P/E (TTM)
22.3
27.5
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
GMED
متوسط الأقران
Operating Margin (هامش التشغيل)
16.3%
—
Net Profit Margin (هامش صافي الربح)
18.3%
9.8%
ROA (العائد على الأصول)
10.2%
5.1%
ROE
12.1%
8.6%
ROIC
9.3%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
GMED
متوسط الأقران
Current Ratio (النسبة الحالية)
4.3
2.7
Quick Ratio (النسبة السريعة)
2.5
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
GMED
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
16.7%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
42.2%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
30.1%
—
EPS YoY (ربحية السهم على أساس سنوي)
422.7%
—
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
422.3%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
GMED
متوسط الأقران
GMED توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
23 محللين
- شراء قوي 4 17,4%
- شراء 12 52,2%
- احتفاظ 7 30,4%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
13 محللين · 2026-08-15
الوسيط
$100.00
الآن
$88.45
منخفض
$84.00
مرتفع
$125.00
السعر المستهدف الوسيط
$100.00
+13,1%
السعر المستهدف المتوسط
$103.23
+16,7%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.15%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $1.34 | $1.12 | 0.22% |
| 31 مارس، 2026 | $1.12 | $0.94 | 0.18% |
| 31 ديسمبر، 2025 | $1.28 | $1.17 | 0.11% |
| 30 سبتمبر، 2025 | $1.18 | $0.80 | 0.38% |
| 30 يونيو، 2025 | $0.86 | $0.77 | 0.09% |
| 31 مارس، 2025 | $0.68 | $0.76 | -0.08% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| GMED | — | 22.3 | 16.7% | 18.3% | 12.1% | — |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | — | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
الميزانية العمومية 26
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
التدفق النقدي 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
السيولة والملاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
معدلات النمو 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
قائمة الدخل 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | -271,249,000 | 134,502,000 | 135,205,000 | 136,757,000 | -270,442,000 | 135,615,000 | 135,195,000 | 135,358,000 | -201,102,000 | 113,537,000 | 100,373,000 | 100,279,000 | -201,454,000 | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | -274,611,000 | 135,394,000 | 136,499,000 | 139,774,000 | -272,536,000 | 138,062,000 | 136,979,000 | 135,358,000 | -204,593,000 | 115,245,000 | 101,782,000 | 102,196,000 | -205,735,000 | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
الميزانية العمومية 25
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
التدفق النقدي 14
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
الربحية 8
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
السيولة والملاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
التقييم (آخر 12 شهرًا) 4
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.06B | $2.87B | · | $2.74B | $2.60B | $2.46B | · | $2.25B | $1.91B | $1.56B | · | $1.21B | $1.09B | $1.03B | · | $978M | |
| Net Income TTM | $598M | $522M | · | $449M | $362M | $152M | · | $77M | $83M | $101M | · | $155M | $209M | $189M | · | $187M | |
| P/E | 18.1 | 22.6 | · | 17.4 | 22.4 | 66.5 | · | 125.5 | 90.1 | 53.1 | · | 32.5 | 29.0 | 30.6 | · | 32.7 | |
| Earnings Yield | 5.5% | 4.4% | · | 5.7% | 4.5% | 1.5% | · | 0.80% | 1.1% | 1.9% | · | 3.1% | 3.4% | 3.3% | · | 3.1% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| هامش الربح الإجمالي % | — | — | 65.0% | — | 75.0% |
| هامش الربح التشغيلي % | 16.3% | 6.6% | 8.5% | — | 17.9% |
| صافي الدخل | $538M | $103M | $123M | $190M | $149M |
| EPS المخفف | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 4.3 | 2.5 | 4.9 | — | 6.2 |
| النسبة السريعة | 2.5 | 0.8 | 1.4 | — | 3.0 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $589M | $405M | $165M | — | $219M |
إشارات التداول إشارات شراء/بيع حديثة مع سعر الدخول ونسبة المخاطرة/المكافأة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 642 مقدمي إقرار · $5.7B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 82 (-27 مقابل الربع السابق) | 80 (+30 مقابل الربع السابق) | 241 (+22 مقابل الربع السابق) | 176 (-6 مقابل الربع السابق) | +11.4M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $403546103 | 5107532 | 7,04% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394606359 | 4994385 | 6,89% | الأسهم |
| STATE STREET CORP | $293540630 | 3714029 | 5,12% | الأسهم |
| Sculptor Capital LP | $237030000 | 3000000 | 4,14% | الأسهم |
| Burgundy Asset Management Ltd. | $212054428 | 3460983 | 3,70% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $205090439 | 2380344 | 3,58% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $166610599 | 2108728 | 2,91% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135630225 | 1716621 | 2,37% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $134690079 | 1704191 | 2,35% | الأسهم |
| Boston Partners | $112054767 | 1418394 | 1,96% | الأسهم |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101519633 | 1284896 | 1,77% | الأسهم |
| Quantinno Capital Management LP | $96320933 | 1219098 | 1,68% | الأسهم |
| NORGES BANK | $89048300 | 1127051 | 1,55% | الأسهم |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88055393 | 1114484 | 1,54% | الأسهم |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88048981 | 1114403 | 1,54% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84736329 | 1072476 | 1,48% | الأسهم |
| GENEVA CAPITAL MANAGEMENT LLC | $78941870 | 999138 | 1,38% | الأسهم |
| Madison Avenue Partners, LP | $73891416 | 935216 | 1,29% | الأسهم |
| Boston Trust Walden Corp | $73637557 | 932003 | 1,28% | الأسهم |
| ANTIPODES PARTNERS Ltd | $71581796 | 905984 | 1,25% | الأسهم |
| Global Alpha Capital Management Ltd. | $67681230 | 856616 | 1,18% | الأسهم |
| Vestal Point Capital, LP | $67158500 | 850000 | 1,17% | الأسهم |
| VANGUARD GROUP INC | $59221500 | 678290 | 1,03% | الأسهم |
| Stephens Investment Management Group LLC | $57159864 | 723451 | 1,00% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $56575822 | 716059 | 0,99% | الأسهم |
| Clark Capital Management Group, Inc. | $54271890 | 686899 | 0,95% | الأسهم |
| AMERICAN CAPITAL MANAGEMENT INC | $51599219 | 653072 | 0,90% | الأسهم |
| ANCHOR CAPITAL ADVISORS LLC | $51225201 | 648338 | 0,89% | الأسهم |
| Camber Capital Management LP | $47216000 | 800000 | 0,82% | الأسهم |
| Capital World Investors | $46664254 | 590612 | 0,81% | الأسهم |
| Artemis Investment Management LLP | $45305914 | 573420 | 0,79% | الأسهم |
| Swedbank AB | $41113881 | 520363 | 0,72% | الأسهم |
| OBERWEIS ASSET MANAGEMENT INC/ | $40461021 | 512100 | 0,71% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $39194096 | 496065 | 0,68% | الأسهم |
| Paradice Investment Management LLC | $39023513 | 493906 | 0,68% | الأسهم |
| Soleus Capital Management, L.P. | $37049527 | 468922 | 0,65% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $34953155 | 442389 | 0,61% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $34559104 | 437402 | 0,60% | الأسهم |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $33569453 | 424876 | 0,59% | الأسهم |
| FIRST TRUST ADVISORS LP | $32942568 | 416943 | 0,57% | الأسهم |
| FMR LLC | $32503608 | 411386 | 0,57% | الأسهم |
| Grantham, Mayo, Van Otterloo & Co. LLC | $32370792 | 409705 | 0,56% | الأسهم |
| Holocene Advisors, LP | $31598627 | 399932 | 0,55% | الأسهم |
| Pembroke Management, LTD | $31513929 | 398860 | 0,55% | الأسهم |
| GOLDMAN SACHS GROUP INC | $31286538 | 395982 | 0,55% | الأسهم |
| Annex Advisory Services, LLC | $30189344 | 350387 | 0,53% | الأسهم |
| Bares Capital Management, Inc. | $29845058 | 521129 | 0,52% | الأسهم |
| Capital Impact Advisors, LLC | $29246895 | 370167 | 0,51% | الأسهم |
| SIRIOS CAPITAL MANAGEMENT L P | $28050051 | 355019 | 0,49% | الأسهم |
| Bridgewater Associates, LP | $27809466 | 351974 | 0,49% | الأسهم |
| CONGRESS ASSET MANAGEMENT CO | $26754761 | 338625 | 0,47% | الأسهم |
| Terril Brothers, Inc. | $25403295 | 321520 | 0,44% | الأسهم |
| Sio Capital Management, LLC | $23846482 | 301816 | 0,42% | الأسهم |
| SEGALL BRYANT & HAMILL, LLC | $23729389 | 300334 | 0,41% | الأسهم |
| Champlain Investment Partners, LLC | $22982271 | 290878 | 0,40% | الأسهم |
| RHUMBLINE ADVISERS | $22513223 | 284942 | 0,39% | الأسهم |
| Gotham Asset Management, LLC | $22364413 | 283058 | 0,39% | الأسهم |
| UBS Group AG | $22286430 | 282071 | 0,39% | الأسهم |
| KENNEDY CAPITAL MANAGEMENT LLC | $22020640 | 278707 | 0,38% | الأسهم |
| MetLife Investment Management, LLC | $21771680 | 275556 | 0,38% | الأسهم |
| Kathmere Capital Management, LLC | $21450978 | 271497 | 0,37% | الأسهم |
| Retirement Systems of Alabama | $20830354 | 263642 | 0,36% | الأسهم |
| Foresight Group Ltd Liability Partnership | $19759724 | 254030 | 0,34% | الأسهم |
| NICHOLAS COMPANY, INC. | $19699484 | 249329 | 0,34% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $19524872 | 247119 | 0,34% | الأسهم |
| Varenne Capital Partners | $18807009 | 238200 | 0,33% | الأسهم |
| GLENMEDE TRUST CO NA | $18639881 | 235918 | 0,33% | الأسهم |
| Mesirow Institutional Investment Management, Inc. | $18549041 | 224266 | 0,32% | الأسهم |
| California Public Employees Retirement System | $18120944 | 229350 | 0,32% | الأسهم |
| Woodline Partners LP | $17906826 | 226640 | 0,31% | الأسهم |
| Swiss National Bank | $17862344 | 226077 | 0,31% | الأسهم |
| Corient Private Wealth LP | $17322828 | 219248 | 0,30% | الأسهم |
| GABELLI FUNDS LLC | $16671110 | 211000 | 0,29% | الأسهم |
| Lightrock Netherlands B.V. | $16367000 | 207151 | 0,29% | الأسهم |
| Sofinnova Investments, Inc. | $15802000 | 200000 | 0,28% | عقد خيار الشراء |
| RENAISSANCE TECHNOLOGIES LLC | $15558491 | 196918 | 0,27% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $15455225 | 195611 | 0,27% | الأسهم |
| LPL Financial LLC | $15233500 | 192805 | 0,27% | الأسهم |
| Susquehanna Portfolio Strategies, LLC | $15165574 | 191945 | 0,26% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $14032018 | 177598 | 0,24% | الأسهم |
| Leith Wheeler Investment Counsel Ltd. | $13821540 | 174934 | 0,24% | الأسهم |
| BlackRock, Inc. | $13638706 | 172620 | 0,24% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $13486770 | 170697 | 0,24% | الأسهم |
| WCM INVESTMENT MANAGEMENT, LLC | $13455918 | 160304 | 0,23% | الأسهم |
| Leeward Investments, LLC - MA | $12983476 | 164327 | 0,23% | الأسهم |
| Walleye Capital LLC | $12358823 | 156421 | 0,22% | الأسهم |
| JANUS HENDERSON GROUP PLC | $12232394 | 141973 | 0,21% | الأسهم |
| Bellevue Group AG | $11543993 | 146108 | 0,20% | الأسهم |
| Sterling Investment Advisors, Ltd. | $11379257 | 144023 | 0,20% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $11223202 | 130260 | 0,20% | الأسهم |
| Defilade Capital Management, L.P. | $11032719 | 139637 | 0,19% | الأسهم |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $10934984 | 138400 | 0,19% | الأسهم |
| Glenmede Investment Management, LP | $10909935 | 190500 | 0,19% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $10809042 | 136806 | 0,19% | الأسهم |
| ALGERT GLOBAL LLC | $10560477 | 133660 | 0,18% | الأسهم |
| GAMCO INVESTORS, INC. ET AL | $10209435 | 129217 | 0,18% | الأسهم |
| ArrowMark Colorado Holdings LLC | $9102268 | 115204 | 0,16% | الأسهم |
| STRS OHIO | $8815936 | 111580 | 0,15% | الأسهم |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $8503609 | 107627 | 0,15% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $8430130 | 106697 | 0,15% | الأسهم |
المطلعون على الشركة 22 من المطلعين · مسؤولون 11 · مديرون 15
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | 21 يناير، 2026 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | 23 يناير، 2025 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | 27 يناير، 2022 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | 21 يناير، 2026 A | 0 | 0 | 2 | $-2032133 |
| Richard A Baron | Senior VP and CFO | 2 مايو، 2014 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | 7 مارس، 2019 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | 25 فبراير، 2026 M | 0 | 0 | 3 | $-3441700 |
| David C Paul | Executive Chairman | 21 يناير، 2026 A | 60417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | 1 فبراير، 2019 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | 25 يونيو، 2018 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | 2 فبراير، 2018 A | 35217 | 0 | 0 | $0 |
| David D Davidar | مدير | 27 يوليو، 2026 G | 507675 | 0 | 2 | $-4169000 |
| Ann D Rhoads | مدير | 4 يونيو، 2026 M | 40384 | 0 | 3 | $-1402600 |
| Dan Wolterman | مدير | 21 يناير، 2026 A | 24025 | 0 | 0 | $0 |
| Leslie V Norwalk | مدير | 21 يناير، 2026 A | 10419 | 0 | 2 | $-557600 |
| Dan Lemaitre | مدير | 21 يناير، 2026 A | 0 | 0 | 0 | $0 |
| John A Deford | مدير | 21 يناير، 2026 A | 15578 | 0 | 0 | $0 |
| Robert Andrew Douglas | مدير | 21 يناير، 2026 A | 2005 | 0 | 0 | $0 |
| Stephen T Zarrilli | مدير | 21 يناير، 2026 A | 0 | 0 | 1 | $-2107250 |
| James R Tobin | مدير | 21 يناير، 2026 A | 0 | 0 | 0 | $0 |
| Kurt Wheeler | مدير | 22 يناير، 2019 A | 44319 | 0 | 0 | $0 |
| Robert Liptak | مدير | 22 يناير، 2019 A | 26159 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 99 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 2,27% | 219621 NS | 30 إبريل، 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,93% | 118993 SH | 8 أغسطس، 2026 | يومي |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,86% | 10979 NS | 30 إبريل، 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1,53% | 21591 NS | 30 إبريل، 2026 | N-PORT |
| IHI · iShares Trust | 1,30% | 536949 SH | 8 أغسطس، 2026 | يومي |
| LFSC · RBB Fund, Inc. | 1,27% | 16258 NS | 31 مايو، 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,24% | 242837 NS | 30 إبريل، 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 0,87% | 7891 NS | 31 مايو، 2026 | N-PORT |
| TAX · EA Series Trust | 0,86% | 2682 NS | 29 مايو، 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,86% | 37446 SH | 8 أغسطس، 2026 | يومي |
| LSEQ · Harbor ETF Trust | 0,83% | 1408 NS | 30 إبريل، 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 0,82% | 90 NS | 30 إبريل، 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,55% | 31832 NS | 30 إبريل، 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,54% | 2130 NS | 31 مايو، 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0,51% | 11913 SH | 8 أغسطس، 2026 | يومي |
| IJK · iShares Trust | 0,49% | 662259 SH | 8 أغسطس، 2026 | يومي |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,47% | 111810 SH | 8 أغسطس، 2026 | يومي |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,39% | 2462 NS | 31 مايو، 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 18545 NS | 30 إبريل، 2026 | N-PORT |
| GQQQ · EA Series Trust | 0,34% | 5950 NS | 29 مايو، 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,31% | 21679 NS | 30 إبريل، 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,29% | 12781 NS | 30 إبريل، 2026 | N-PORT |
| XJH · iShares Trust | 0,29% | 15314 SH | 8 أغسطس، 2026 | يومي |
| ISCG · iShares Trust | 0,29% | 35610 SH | 8 أغسطس، 2026 | يومي |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,29% | 42239 NS | 30 إبريل، 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,29% | 3969 NS | 30 إبريل، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,28% | 26195 NS | 31 مايو، 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,28% | 15001 SH | 8 أغسطس، 2026 | يومي |
| ANEW · ProShares Trust | 0,26% | 244 NS | 31 مايو، 2026 | N-PORT |
| IJH · iShares Trust | 0,25% | 3909873 SH | 8 أغسطس، 2026 | يومي |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,25% | 183180 SH | 8 أغسطس، 2026 | يومي |
| VBK · VANGUARD INDEX FUNDS | 0,24% | 1499816 SH | 8 أغسطس، 2026 | يومي |
| CLSE · Trust for Professional Managers | 0,23% | 17617 NS | 31 مايو، 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,22% | 5809 NS | 31 مايو، 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,21% | 56008 NS | 30 إبريل، 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 46648 NS | 30 إبريل، 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,20% | 1845 NS | 30 إبريل، 2026 | N-PORT |
| MVV · ProShares Trust | 0,20% | 3849 NS | 31 مايو، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,19% | 535955 NS | 31 مايو، 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,17% | 2091 NS | 31 مايو، 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,17% | 300905 NS | 31 مايو، 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,16% | 8751 NS | 30 إبريل، 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,16% | 51771 NS | 30 إبريل، 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 7980 NS | 30 إبريل، 2026 | N-PORT |
| IYH · iShares Trust | 0,15% | 67336 SH | 8 أغسطس، 2026 | يومي |
| REVS · Columbia ETF Trust I | 0,15% | 4563 NS | 30 إبريل، 2026 | N-PORT |
| ISCB · iShares Trust | 0,14% | 5059 SH | 8 أغسطس، 2026 | يومي |
| UMDD · ProShares Trust | 0,14% | 538 NS | 31 مايو، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,13% | 338547 SH | 8 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,13% | 199853 NS | 30 إبريل، 2026 | N-PORT |